METASTATIC COLORECTAL CANCER PATIENTS WITH KRAS MUTATED TUMORS

Clinical trials for METASTATIC COLORECTAL CANCER PATIENTS WITH KRAS MUTATED TUMORS explained in plain language.

Never miss a new study

Get alerted when new METASTATIC COLORECTAL CANCER PATIENTS WITH KRAS MUTATED TUMORS trials appear

Sign up with your email to follow new studies for METASTATIC COLORECTAL CANCER PATIENTS WITH KRAS MUTATED TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for tough-to-treat colon cancer patients after standard drugs fail

Disease control Completed

This study tested whether adding the drug sorafenib to irinotecan chemotherapy works better than either drug alone for people with advanced colorectal cancer that has a specific genetic change (KRAS mutation) and has stopped responding to all standard treatments. It involved 173 …

Matched conditions: METASTATIC COLORECTAL CANCER PATIENTS WITH KRAS MUTATED TUMORS

Phase: PHASE2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

METASTATIC COLORECTAL CANCER PATIENTS WITH KRAS MUTATED TUMORS

Get alerted when new METASTATIC COLORECTAL CANCER PATIENTS WITH KRAS MUTATED TUMORS trials appear

New hope for tough-to-treat colon cancer patients after standard drugs fail